Clinical Trial Update: Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Angelica Sinensis for hot flashes in men undergoing LHRH therapy for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Angelica Sinensis (Angelica sinensis)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED